arrow_back Trending Legislation
Share share

Streamlining Lab Tests: Faster Access to Medical Diagnostics

This act aims to simplify how laboratories develop and use their own medical tests, potentially speeding up disease diagnosis, especially during crises. The changes are designed to ensure tests are accurate without unnecessary hurdles that could delay patient access. Citizens can expect quicker access to new diagnostic methods.
Key points
All laboratory-developed tests will be regulated by a single authority (Department of Health and Human Services), simplifying the process.
The act aims to prevent delays in test access, especially during epidemics like COVID-19.
Ensures laboratories can quickly respond to public health emergencies by providing more testing capacity.
Requires a public meeting and a report to gather feedback and update regulations for laboratory tests.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
VITAL Act of 2021
Print number: S 1666
Sponsor: Sen. Paul, Rand [R-KY]
Process start date: 2021-05-18
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Streamlining Lab Tests: Faster Access to Medical Diagnostics

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is S 1666.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2021-05-18.

What are the main provisions?

Key points include:

  • All laboratory-developed tests will be regulated by a single authority (Department of Health and Human Services), simplifying the process.
  • The act aims to prevent delays in test access, especially during epidemics like COVID-19.
  • Ensures laboratories can quickly respond to public health emergencies by providing more testing capacity.
  • Requires a public meeting and a report to gather feedback and update regulations for laboratory tests.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Paul, Rand [R-KY].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-29.

Analysis and Potential Impact of S 1666

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health